IMMUTEP LIMITED - Charts / Financials

Market Cap $486.6M Add to my watchlist

Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company... Immutep Limited is an Australia-based clinical-stage biotechnology company. The Company is focused on developing Lymphocyte Activation Gene (LAG)-3 immunotherapies for cancer and autoimmune diseases. Its lead product candidate, Eftilagimod alpha (efti or IMP321), is a soluble LAG-3Ig fusion protein that is an antigen-presenting cell (APC) agonist designed to capitalize on LAG-3’s ability to drive the adaptive and innate immune systems against cancer. IMP761 is an immunosuppressive agonist antibody to LAG-3, which has the potential to address the root cause of autoimmune diseases by specifically silencing autoimmune memory T cells. Its third product candidate is LAG525, an antagonist (blocking) antibody targeting the LAG-3 molecule on T cells with potential applications in the treatment of cancer. Its fourth product candidate is IMP731 (GSK 781), a depleting (cytotoxic) antibody that is intended to destroy LAG-3 expressing activated T cells involved in autoimmunity.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

REFRESH

Last update - 15.59pm 03/12/2024 (20 minute delay)

Day
Open	31.0¢		Day High	32.5¢		Day Low	31.0¢
Daily Volume	1392912

Bids				Sellers
Number	Price	Volume		Number	Price	Volume
1	32.0¢	15000		5	32.5¢	462081

Directors & Senior Management

Mr. Marc Voigt	Chief Executive Officer, Executive Director
Ms. Deanne Miller	Chief Operating Officer, General Counsel, Joint Company Secretary
Dr. Frederic Triebel	Chief Scientific Officer, Executive Director
Mr. Florian D. Vogl	Chief Medical Officer
Ms. Indira Naidu	Joint Company Secretary
Dr. Russell John Howard	Independent Non-Executive Chairman of the Board
Mr. Peter A. Meyers	Independent Non-Executive Deputy Chairman of the Board
Ms. Lis Boyce	Non-Executive Director
Ms. Anne Anderson	Independent Non-Executive Director

Data source: Refinitiv

(20min delay)
Last 32.5¢		Change 0.005(1.56%)		Mkt cap ! $486.6M

Open	High	Low	Value	Volume
31.0¢	32.5¢	31.0¢	$443.3K	1.392M

Buyers (Bids)

No.	Vol.	Price($)
1	15000	32.0¢

Sellers (Offers)

Price($)	Vol.	No.
32.5¢	462081	5

View Market Depth

No.	Vol.	Price($)
4	115519	0.395
3	76000	0.390
4	68064	0.385
10	225656	0.380
1	8500	0.375

Price($)	Vol.	No.
0.405	37481	2
0.410	240538	10
0.415	229395	10
0.420	502644	9
0.425	50700	3

Last trade - 16.10pm 03/12/2024 (20 minute delay)


Last 32.5¢		Change 0.005 ( 0.43 %)
Open	High	Low	Volume
31.5¢	32.5¢	31.5¢	735148
Last updated 15.59pm 03/12/2024 ?

IMM (ASX) Chart